Tiffany was a force. A driving energy connecting patients, scientists, clinicians, and industry—always pushing for better care, stronger research, and...
Amicus Therapeutics announces that the European Commission (EC) has granted approval for Opfolda® (miglustat), an enzyme stabilizer of cipaglucosidase alfa, an...